Scorpion Capital

Scorpion Capital specializes in intensive, differentiated research which uncovers what investors have missed and Wall Street is paid to ignore. It conducts rigorous due diligence on each fraud or promote that it targets. Scorpion Capital's investigations seek to crack the case through a persistent and thorough process for which other market participants may lack the bandwidth or inclination.

The four activist shorts on which Scorpion Capital has published and has each generated strong absolute and relative performance:

  • Jan 7, 2021 Nevro (NVRO)
  • Dec 18, 2019 Allakos (ALLK)
  • Dec 18, 2018 Axogen (AXGN)
  • Aug 27, 2018 Fanhua (FANH)

*ALLK, AXGN, and FANH were published on behalf of and by a previous firm.